An interventional study of Personalized Physical Activity coaching program and Free practice of physical activity in Parkinson's Disease, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment
Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's d…PubMed 40088781 ↗. 2 publications citing this study linked from PubMed
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand — 5 open to participants now, 5 under way, none of them phase 3. Parkinson Disease · University Hospital, Clermont-Ferrand.
Among the 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand, this one is the 12th largest by enrollment of the 23 interventional ones that give a count, is one of 4 that started in 2016, is one of 18 with no phase, and was the 11th registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →5 of the 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand · Sites in France
Ages 18–75 · Healthy volunteers
University Hospital, Clermont-Ferrand · Sites in France
Ages 18–90
University Hospital, Clermont-Ferrand · Sites in France
Ages 18–80
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 4 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 46 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 46 across the 23 interventional studies, 250 across the 2 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
2 of the studies in Parkinson Disease by University Hospital, Clermont-Ferrand that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07702266University Hospital, Clermont-FerrandPrimary Parkinsonian Pain: Clinical Association and Phenotype | 2027-09-30 |
| NCT07813156University Hospital, Clermont-FerrandIdiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD) | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand, from their registry updates:
This tab as a report to print or save as PDF → With an account.
There is growing interest for physical activity in Parkinson's disease in order to improve mobility and function of these patients. It seems from previous studies that difficulty, intensity and specificity of physical exercises are important parameters conditioning the effect of physical activity on cerebral plasticity and clinical improvement.
Thus, the aim of this study is to evaluate the benefits of a Personalized Physical Activity coaching program, including scheduled and frequent follow up associated with progressive readaptation of exercise intensity depending on individual performances (during 3 months), versus free practice of physical activity in Parkinson's disease.
Type of study: a randomized, single-blind, parallel-group, controlled clinical trial.
Number of centers: 1 (Clermont-Ferrand)
Patients
Patients eligible for inclusion will be randomized to one of the two groups:
Study Performance Patients will be evaluated 3 times : at J0 (baseline, V1), 3 months after Personalized Physical Activity coaching program (J0+3M, V2), and 3 months after the end of the Personalized Physical Activity coaching program (J0+6M)
V1:
V1, V2, V3
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
APA + : patients will beneficiate of Personalized Physical Activity coaching program during 3 months (1 hour, twice by week, during 3 months)
Behavioral: Personalized Physical Activity coaching program
APA- : patients will do free practice of physical activity during 3 months.
Behavioral: Free practice of physical activity
Change from baseline of the Unified Parkinson Disease Rating Scale part III score
Time frame: at +3months
Change from baseline of Parkinson's Disease Questionnaire 39-item version score
Time frame: at +3months
Change from baseline of the Lawton and Brody Activities of Daily Living scale score
Time frame: at +3months
Change from baseline of the percentage of sedentarity, mild, moderate and intense activity using the eMOUVE application
Time frame: at +3months
Change from baseline of percentage of sedentarity, mild, moderate and intense activity using the eMOUVE application
Time frame: at + 6 months
Change from baseline of balancing abilities measured by stabilometry
Time frame: at +3months
Change from baseline of balancing abilities measured by stabilometry
Time frame: at + 6 months
Change from baseline of muscular strength measured with isometric test
Time frame: at +3months
Change from baseline of muscular strength measured with isometric test
Time frame: at +6months
Change from baseline of VO2pic
Time frame: at +3months
Change from baseline of VO2pic
Time frame: at + 6 months
Change from baseline of the 6 min Walking Test score
Time frame: at +3 months
Change from baseline of the 6 min Walking Test score
Time frame: at + 6 months
Change from baseline of fat and lean body mass measured by DEXA
Time frame: at +3 months.
Change from baseline fat and lean body mass measured by DEXA
Time frame: at +6 months.
dropout rates
Time frame: at +3 months
dropout rates
Time frame: at +6 months
Ran from Mar 2016 to primary completion in Jun 2018, 27 months.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 27 months is above that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's d…PubMed 40088781 ↗. 2 publications citing this study linked from PubMed
Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's d…PubMed 40088781 ↗. 2 publications citing this study linked from PubMed
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →